Tandem Diabetes Care Inc (TNDM) — Cash Flow Reinvestment Rate
Tandem Diabetes Care Inc (TNDM) has a Cash Flow Reinvestment Rate of 17.68x as of March 2026, reinvesting $195.45 Million (capex $6.27 Million plus investments $-189.18 Million) from operating cash flow of $11.05 Million. Explore how much does Tandem Diabetes Care Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tandem Diabetes Care Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Tandem Diabetes Care Inc across 5 annual periods. Also explore Tandem Diabetes Care Inc (TNDM) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tandem Diabetes Care Inc (2019–2024)
Year-by-year capital reinvestment analysis for Tandem Diabetes Care Inc. For live market cap and broader valuation context, see market value of Tandem Diabetes Care Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.76x | $42.71 Million | $24.23 Million | $19.23 Million | ▲ +32.3% |
| 2022 | 1.33x | $67.27 Million | $50.46 Million | $34.10 Million | ▼ -20.6% |
| 2021 | 1.68x | $186.88 Million | $111.36 Million | $23.51 Million | ▼ -86.0% |
| 2020 | 12.00x | $296.06 Million | $24.67 Million | $32.29 Million | ▲ +783.0% |
| 2019 | 1.36x | $56.95 Million | $41.91 Million | $19.54 Million | — |